Advertisement

Click here for more guidelines.

 
 




CME Topic Collections Past Issues Search Current Issue Home
     

Right arrow Help viewing high resolution images
Right arrow Return to article

Please click here to obtain permission to reproduce this image.

Click on image to view larger version.


Figure 6


Figure 6 Infused FBF in Subjects During Infusion

Infused FBF in subjects during infusion of (top row) (Pyr1)apelin-13 in the presence (solid squares) or absence (open squares) of nitric oxide (NO) clamp (left) or aspirin (right) and (bottom row) acetylcholine in the presence (solid circles) or absence (open circles) of NO clamp (left) or aspirin (right). p < 0.0001; 1-way ANOVA for dose responses to (Pyr1)apelin-13 and acetylcholine alone. For placebo versus NO clamp (AUC): (Pyr1)apelin-13, p < 0.01; acetylcholine, p < 0.05. For placebo versus aspirin (AUC): (Pyr1)apelin-13, p = 0.7; acetylcholine, p = 0.9. AUC = area under the curve; other abbreviations as in Figure 3.





Right arrow Return to article

 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement